Bracco S.p.A. — Bracco Imaging
Tracked across 2 events · 13 articles · First seen Apr 20, 2026 · Last active Aug 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Bracco S.p.A. — Bracco Imaging entered into a multi-year Master Research Agreement with NYU Langone Health to advance medical imaging innovation, which is expected to enhance its diagnostic solutions portfolio.
Apr 20, 2026 · 6 articles
Regulatory
Bracco S.p.A. — Bracco Imaging announced on August 11, 2026, that its VueJect ultrasound contrast delivery system received 510(k) clearance from the U.S. United States — Food and Drug Administration and authorization from Canada —…
Impact: Bracco S.p.A. — Bracco Imaging is the developer and manufacturer of VueJect, and the regulatory approvals enable its commercial launch in North America, supporting its CEUS ecosystem and growth strategy.
Aug 11, 2026 · 7 articles
90
United States — Food and Drug Administration granted clearance Bracco S.p.A. — Bracco ImagingBracco VueJect FDA and...
90
Canada — Health Canada granted authorization Bracco S.p.A. — Bracco ImagingBracco VueJect FDA and...
ERGEN INTELLIGENCE
Track Bracco S.p.A. — Bracco Imaging live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard